GAF Healthcare
Specialty Overview

Best Hospitals for Chemotherapy in Chennai, India

8 radiation oncology hospitals in our India network are listed in Chennai, accredited by JCI, NABH, NABL, with 4,035 beds combined.

8
Hospitals Listed
1
City
4.5
Avg. Rating
3
Accreditation Types
The Short Answer

This page lists the radiation oncology hospitals in our directory offering Chemotherapy in Chennai, India, including Apollo Hospitals, Greams Road, Gleneagles Global Hospital, Dr. Rela Institute and Medical Centre, SIMS Hospital and others. Each listing links through to the hospital's full profile page.

Including:🇮🇳 Apollo Hospitals, Greams Road🇮🇳 Gleneagles Global Hospital🇮🇳 Dr. Rela Institute and Medical Centre

Ask us about chemotherapy in Chennai, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 8 accredited hospitals for Radiation Oncology in Chennai, India

Apollo Hospitals, Greams Road Featured
Starting from$1,000

🇮🇳 Apollo Hospitals, Greams Road

Chennai, India 4.7 (125 reviews) 560 beds
Why consider this hospital?
4.7/5 rating from 125 reviewsAccredited by JCI, NABH560 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering chemotherapy can be cared for by Apollo Hospitals, Greams Road's care team in Chennai, India, from initial consultation through recovery. Apollo Hospitals, Greams Road, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing chemotherapy.

4.7/5
Rating
1983
Established
560
Beds
Chennai, India
Location
Enquire NowView Profile
Gleneagles Global Hospital
Starting from$1,000

🇮🇳 Gleneagles Global Hospital

Chennai, India 4.7 (112 reviews) 1,000 beds
Why consider this hospital?
4.7/5 rating from 112 reviewsAccredited by NABH, JCI1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by NABH, JCI

Patients considering chemotherapy can be cared for by Gleneagles Global Hospital's care team in Chennai, India, from initial consultation through recovery. Gleneagles Global Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing chemotherapy.

4.7/5
Rating
1999
Established
1,000
Beds
Chennai, India
Location
Enquire NowView Profile
Dr. Rela Institute and Medical Centre
Starting from$1,000

🇮🇳 Dr. Rela Institute and Medical Centre

Chennai, India 4.7 (108 reviews) 450 beds
Why consider this hospital?
4.7/5 rating from 108 reviewsAccredited by NABH, NABL450 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by NABH, NABL

Patients considering chemotherapy can be cared for by Dr. Rela Institute and Medical Centre's care team in Chennai, India, from initial consultation through recovery. Dr. Rela Institute and Medical Centre, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing chemotherapy.

4.7/5
Rating
2018
Established
450
Beds
Chennai, India
Location
Enquire NowView Profile
SIMS Hospital
Starting from$1,000

🇮🇳 SIMS Hospital

Chennai, India 4.6 (20 reviews) 345 beds
Why consider this hospital?
4.6/5 rating from 20 reviewsAccredited by NABH, JCI345 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantOrthopedicsGastroenterology
Accredited by NABH, JCI

Patients considering chemotherapy can be cared for by SIMS Hospital's care team in Chennai, India, from initial consultation through recovery. SIMS Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing chemotherapy.

4.6/5
Rating
1970
Established
345
Beds
Chennai, India
Location
Enquire NowView Profile
Sankara Nethralaya
Starting from$1,000

🇮🇳 Sankara Nethralaya

Nungambakkam, Chennai, India 4.4 (220 reviews) 200 beds
Why consider this hospital?
4.4/5 rating from 220 reviewsAccredited by NABH, NABL200 beds
Specialties & Accreditation
OphthalmologyRetina SurgeryCornea TransplantGlaucomaPediatric Ophthalmology
Accredited by NABH, NABL

Patients considering chemotherapy can be cared for by Sankara Nethralaya's care team in Nungambakkam, Chennai, India, from initial consultation through recovery. Sankara Nethralaya, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing chemotherapy.

4.4/5
Rating
1978
Established
200
Beds
Nungambakkam, Chennai, India
Location
Enquire NowView Profile
Apollo First Med Hospitals, Kilpauk
Starting from$1,000

🇮🇳 Apollo First Med Hospitals, Kilpauk

Kilpauk, Chennai, India 4.4 (76 reviews) 80 beds
Why consider this hospital?
4.4/5 rating from 76 reviewsAccredited by NABH, JCI80 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurologyOncologyGastroenterology
Accredited by NABH, JCI

Patients considering chemotherapy can be cared for by Apollo First Med Hospitals, Kilpauk's care team in Kilpauk, Chennai, India, from initial consultation through recovery. Apollo First Med Hospitals, Kilpauk, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing chemotherapy.

4.4/5
Rating
2002
Established
80
Beds
Kilpauk, Chennai, India
Location
Enquire NowView Profile
MIOT International
Starting from$1,000

🇮🇳 MIOT International

Manapakkam, Chennai, India 4.4 (200 reviews) 1,000 beds
Why consider this hospital?
4.4/5 rating from 200 reviewsAccredited by NABH, NABL, JCI1,000 beds
Specialties & Accreditation
OrthopedicsCardiac SurgeryNeurosciencesTransplantOncology
Accredited by NABH, NABL, JCI

Patients considering chemotherapy can be cared for by MIOT International's care team in Manapakkam, Chennai, India, from initial consultation through recovery. MIOT International, accredited by NABH, NABL, JCI, follows recognised patient-safety and quality-of-care standards when performing chemotherapy.

4.4/5
Rating
1999
Established
1,000
Beds
Manapakkam, Chennai, India
Location
Enquire NowView Profile
MGM Healthcare
Starting from$1,000

🇮🇳 MGM Healthcare

Chennai, India 3.7 (34 reviews) 400 beds
Why consider this hospital?
3.7/5 rating from 34 reviewsAccredited by NABH, JCI400 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantCancer CareOrthopedics
Accredited by NABH, JCI

Patients considering chemotherapy can be cared for by MGM Healthcare's care team in Chennai, India, from initial consultation through recovery. MGM Healthcare, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing chemotherapy.

3.7/5
Rating
1970
Established
400
Beds
Chennai, India
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Radiation Oncology is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Chemotherapy in Chennai, India?

Choosing the right hospital for chemotherapy is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include radiation oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Chemotherapy

Chemotherapy is a systemic cancer treatment using cytotoxic agents to destroy or inhibit the proliferation of malignant cells, administered as a curative, adjuvant, neoadjuvant, or palliative strategy depending on cancer type and stage.

0–3 days per cycle (most cycles are administered as day-care/outpatient infusions; inpatient stays apply for high-dose regimens or stem-cell-supported protocols)
Hospital Stay
1–6 weeks after the final cycle (dependent on nadir recovery, infection risk, and treating oncologist clearance; short-haul travel is often permitted between cycles)
Total Stay in Country (Fit-to-Fly)
60–95% (disease- and stage-specific; e.g., >90% complete remission in Hodgkin lymphoma with ABVD; ~70–80% in early-stage breast cancer with AC-T; ~40–60% objective response in first-line NSCLC platinum doublets)
Success Rate

Clinical Overview

  • Chemotherapy encompasses a broad class of pharmacological agents—alkylating agents, antimetabolites, topoisomerase inhibitors, antimicrotubule agents, platinum analogues, and anthracyclines—each targeting specific vulnerabilities in the cell cycle to induce apoptosis or mitotic arrest in rapidly dividing cells.
  • The physiological impact is systemic: while malignant cells are the primary target, rapidly proliferating normal tissues (bone marrow, gastrointestinal mucosa, hair follicles, and gonads) are also affected, giving rise to the characteristic toxicity profile including myelosuppression, mucositis, nausea, alopecia, peripheral neuropathy, and cardiotoxicity with certain agents such as doxorubicin or trastuzumab.
  • Risk is stratified using validated tools including the Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI), the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH), and ECOG/Karnofsky Performance Status, which guide dose intensity and supportive care planning.
Full details →

Who is a Candidate?

  • Newly diagnosed solid tumor patients (breast, lung, colorectal, gastric, ovarian, bladder, cervical, head & neck) requiring first-line, adjuvant, or neoadjuvant systemic therapy
  • Hematologic malignancy patients (lymphoma, leukemia, multiple myeloma) requiring induction, consolidation, or salvage chemotherapy
  • Patients with metastatic or locally advanced disease where chemotherapy is combined with immunotherapy (checkpoint inhibitors: pembrolizumab, nivolumab, atezolizumab) or targeted agents
  • Candidates for high-dose chemotherapy (HDC) with autologous stem cell rescue (ASCT) for relapsed/refractory lymphoma or multiple myeloma
  • +2 more

Required Pre-Treatment Diagnostics:

Full details →

Treatment Options & Approaches

  • Chemotherapy is not a single treatment but a spectrum of regimens, delivery routes, and combination strategies, individualized based on tumor histology, molecular subtype, stage, comorbidities, and performance status.

Recovery

  • Pre-Treatment Phase (Weeks 1–3 before Cycle 1): Step 1 — Remote Case Submission: Patient submits pathology reports, imaging (PET-CT, MRI, CT), operative notes, and prior treatment records to GAF Healthcare's oncology coordination team.
  • A medical oncologist in India or the UAE performs a virtual consultation within 48–72 hours.
  • Step 2 — Multidisciplinary Tumor Board Review: The treating centre convenes a tumor board (medical oncologist, radiation oncologist, surgical oncologist, pathologist, radiologist) to confirm diagnosis, review molecular profiling (NGS/IHC), and ratify the treatment regimen per NCCN/ESMO guidelines.

Risks to be aware of

  • Chemotherapy carries a well-characterized risk profile that is actively managed through evidence-based supportive care protocols at accredited centres.
  • The most clinically significant acute risk is febrile neutropenia (FN): a potentially life-threatening infection occurring during the nadir period (Days 7–14), with an incidence of 10–40% depending on the regimen; the Multinational Association for Supportive Care in Cancer (MASCC) score is used to risk-stratify FN and guide inpatient versus outpatient antibiotic management.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive end-to-end non-medical coordination for international patients undergoing chemotherapy in India or the UAE, removing the administrative and logistical burden from patients and their families during a demanding treatment journey.

Cost Range for Related Procedures

Cancer Surgery$4,000–$15,000
Chemotherapy$1,000–$4,000
Radiation Therapy$3,500–$10,000
Get a personalised estimate with our cost calculator →

Common questions about Chemotherapy

What is the cost of chemotherapy in India compared to the UAE?
The cost of chemotherapy varies substantially based on the cancer type and stage, the specific regimen prescribed (e.g., standard platinum doublet versus chemo-immunotherapy combinations with agents such as pembrolizumab or trastuzumab deruxtecan), the number of cycles required (typically 4–8), and the need for supportive medications such as G-CSF (pegfilgrastim) or blood products. In India, a complete chemotherapy course at a JCI- or NABH-accredited cancer centre is estimated at USD 1,500–18,000 for a full multi-cycle course. This range covers standard cytotoxic regimens (e.g., AC-T for breast cancer, R-CHOP for lymphoma, BEP for germ-cell tumors) at the lower end, and escalates for high-dose chemotherapy with autologous stem cell transplantation (HDC-ASCT) or regimens incorporating expensive targeted biologics. In the UAE (Dubai or Abu Dhabi), equivalent treatment at JCI-accredited and DHA-licensed oncology hospitals is estimated at USD 4,000–45,000, reflecting higher facility costs, imported drug pricing, and premium hospitality infrastructure. Broadly, India is 50–70% less expensive than the UAE for equivalent oncology protocols. Importantly, both destinations offer access to the same internationally benchmarked chemotherapy regimens, multidisciplinary tumor boards, and modern supportive care. GAF Healthcare provides a detailed, individualized cost estimate within 48–72 hours of reviewing the patient's case records.
How long do I need to stay in the country before I am fit to fly home after chemotherapy?
Unlike single surgical procedures, chemotherapy is administered in cycles over weeks to months, which creates a unique travel planning dynamic. For patients receiving standard outpatient (day-care) chemotherapy regimens every 2–3 weeks, there is typically no absolute medical contraindication to international air travel between cycles, provided the patient has recovered from nadir (blood counts have normalized: ANC ≥1,000/µL, no active fever or infection) and the treating oncologist confirms fitness to travel. This recovery window is generally 10–14 days after each infusion, meaning most patients can travel between cycles if they live within a reasonable flight distance and can return for the next cycle. For patients completing their full course of chemotherapy before returning home (e.g., those traveling from very distant countries), fitness to fly is assessed 2–6 weeks after the final chemotherapy cycle. The key milestones for fit-to-fly clearance are: bone marrow recovery (confirmed CBC), absence of active infection, adequate renal and hepatic function, hemodynamic stability, and absence of severe uncontrolled toxicities such as Grade 3–4 mucositis or peripheral neuropathy. Patients who undergo high-dose chemotherapy with autologous stem cell transplantation require a minimum in-country stay of 4–8 weeks post-transplant before long-haul air travel is considered safe, given the prolonged immune reconstitution period. GAF Healthcare's assigned case manager works directly with the treating oncologist to provide each patient with a precise, personalized fit-to-fly timeline based on their regimen, response, and toxicity profile.
What is the success rate of chemotherapy?
Chemotherapy success rates are highly disease- and stage-specific, and the term 'success' encompasses multiple endpoints: complete remission, overall survival, disease-free survival, progression-free survival, and quality of life. For the most chemosensitive malignancies, outcomes are excellent: Hodgkin lymphoma (ABVD or escalated BEACOPP) achieves complete remission in over 80–90% of patients, with 5-year overall survival exceeding 85–90% even in advanced stages. Testicular germ-cell tumors (BEP regimen) achieve cure rates of 95%+ in good-risk disease and 70–80% in poor-risk disease. Aggressive B-cell lymphoma (DLBCL treated with R-CHOP) achieves cure in approximately 60–70% of patients. For solid tumors, chemotherapy is typically part of a multimodal strategy: in early-stage breast cancer, adjuvant AC-T reduces the risk of recurrence by approximately 30%, contributing to 10-year overall survival exceeding 80–85% for Stage I–II disease. In metastatic settings, chemotherapy alone rarely produces long-term cure, but modern chemo-immunotherapy combinations (e.g., pembrolizumab + carboplatin/paclitaxel in NSCLC) have extended median overall survival to 22+ months in PD-L1-high tumors (KEYNOTE-189). At the JCI-accredited and NABH-certified cancer centres in India, and the JCI/DHA-licensed oncology hospitals in the UAE partnered with GAF Healthcare, treatment protocols strictly follow NCCN and ESMO guidelines, ensuring that patients receive internationally benchmarked regimens delivering outcomes consistent with data from leading global cancer centres. Individual prognosis is discussed in detail during the multidisciplinary tumor board consultation arranged by GAF Healthcare prior to treatment initiation.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Chemotherapy in Chennai, India

Discover the Top Hospitals for Chemotherapy in Chennai, India

This page lists 8 accredited radiation oncology hospitals in Chennai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about chemotherapy in Chennai, India

How many radiation oncology hospitals are listed in Chennai, India?
8 hospitals in our Chennai, India directory are currently listed for radiation oncology including Chemotherapy.
How do you choose which hospitals to list?
A hospital appears on this page when Radiation Oncology is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there radiation oncology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for chemotherapy?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about chemotherapy in Chennai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for chemotherapy in Chennai, India.

Contact us to report an inaccuracy on this page.

WhatsApp Us